SERPINE2 boosts the in vivo invasiveness of its highly metastatic cancer cells via LRP1-mediated induction of MMP9 (35), and SERPINE2 indirectly enhances the invasive potential of cancer cells in PDA by activating surrounding stromal cells (36). The gene discussed is LRP1; the disease is Patent ductus arteriosus.